Acetylsalicylic acid lithium
Catalog No.
C8731
An orally active, irreversible cyclooxygenase (COX-1 and COX-2) inhibitor, also commonly used to induce gastric ulcer models.
Featured Products
Lithium acetylsalicylate (CAS No. 552-98-7) is an orally active, irreversible cyclooxygenase (COX-1 and COX-2) inhibitor with IC₅₀ values of 5 and 210 μg/mL, respectively. This compound can induce apoptosis, inhibit the activation of NF-κB, and inhibit the activity of platelet prostaglandin synthetase. In biomedical research, lithium acetylsalicylate is commonly used to induce gastric ulcer models. The specific application methods and the doses or concentrations used in experiments usually depend on the experimental design and research objectives.
| Storage | 4°C, sealed storage, away from moisture |
| M.Wt | 186.09 |
| Cas No. | 552-98-7 |
| Formula | C9H7LiO4 |
| Synonyms | Aspirin lithium; ASA lithium; Acetylsalicylic acid lithium; Tyllithin |
| Chemical Name | lithium 2-acetoxybenzoate |
| SDF | Download SDF |
| Canonical SMILES | O=C(O[Li])C1=CC=CC=C1OC(C)=O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |